Provided by Tiger Trade Technology Pte. Ltd.

AEON Biopharma

0.3269
+0.036912.72%
Post-market: 0.3100-0.0169-5.17%19:59 EDT
Volume:31.01M
Turnover:10.61M
Market Cap:16.31M
PE:-0.09
High:0.3799
Open:0.2980
Low:0.2903
Close:0.2900
52wk High:1.45
52wk Low:0.1772
Shares:49.88M
Float Shares:30.51M
Volume Ratio:0.75
T/O Rate:101.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5840
EPS(LYR):-3.9532
ROE:--
ROA:-141.53%
PB:-1.06
PE(LYR):-0.08

Loading ...

Company Profile

Company Name:
AEON Biopharma
Exchange:
AMEX
Establishment Date:
- -
Employees:
8
Office Location:
5 Park Plaza,Suite 1750,Irvine,California,United States
Zip Code:
92614
Fax:
- -
Introduction:
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.